Health Condition 1: O- Medical and Surgical
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Age group between 18 & 75 years ASA grade 1,2 & 3 Elective & Emergency surgeries under G.A
Exclusion criteria
Exclusion criteria: Patients not willing to be in the study group, Pregnant patients Known allergy to study drugs Patients with neurological disorders Received analgesic medication Infection at the site of injection thrombophlebitis psychiatric disorders renal, hepatic, or cardiac problems
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the analgesic effect of dexamethasone,lignocaine alone or in combination in reducing the incidence of propofol injection pain. Timepoint: it is evaluated after 1 minute of injecting the study drug , and during the beginning of injection of propofol | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate the severity of propofol injection site pain with Dexamethasone, Lignocaine alone or in combinationTimepoint: severity of propofol injection pain will be assessed at the end of the study approximate duration for total study 3 to 4 months | — |
Countries
India
Contacts
Chettinad Hospital and research institute